Public Release: 

Sticking to lifestyle guidelines may reduce risk for certain cancers and for overall mortality

Albert Einstein College of Medicine

January 7, 2015--(BRONX, NY)--A study of nearly a half-million Americans has found that following cancer prevention guidelines from the American Cancer Society may modestly reduce your overall risk of developing cancer and have a greater impact on reducing your overall risk of dying. Having a healthy body weight and staying active appeared to have the most positive impact.

The observational study--the largest of its kind--by researchers at Albert Einstein College of Medicine of Yeshiva University and its NCI-designated Albert Einstein Cancer Center, found that sticking with the guidelines seems to significantly reduce the risk for developing certain cancers, particularly colorectal cancer in both sexes and endometrial cancer in women. The findings were published online today in the American Journal of Clinical Nutrition.

In 2001, the American Cancer Society (ACS) issued guidelines for preventing cancer. The guidelines recommended that people avoid smoking, achieve and maintain a healthy weight throughout life, be physically active, and eat a healthy diet emphasizing plant foods.

The Einstein researchers stratified study participants into five groups based on how closely they adhered to the ACS guidelines. Men who adhered most closely to the guidelines had a reduced overall risk of developing cancer of 10 percent compared to men with the lowest adherence. For women, the corresponding reduction in overall cancer risk was 19 percent. Men with the highest adherence had a reduced risk of dying from cancer of 25 percent; for women, the reduction was 24 percent. Risk for cancers at various sites varied widely (details below).

Can lifestyle changes reduce risk for cancer?

"The guidelines made sense for overall health, but it was an open question whether they would have an impact on cancer outcomes," said lead author Geoffrey Kabat, Ph.D., senior epidemiologist in the department of epidemiology & population health at Einstein. "Our findings suggest that it's worth the effort to adhere to the ACS guidelines, and that the closer you follow the guidelines, the greater the benefit for preventing certain types of cancer."

Previous studies had shown that health practices such as eating a balanced diet and maintaining a healthy body weight can reduce one's risk of developing or dying from cancer. "However, these studies were relatively small and few looked at the effects on specific types of cancer, which limited the usefulness of the results," said senior author Thomas Rohan, M.B.B.S., Ph.D., professor and chair of epidemiology & population health at Einstein and Montefiore Medical Center, the Harold and Muriel Block Chair in Epidemiology and Population Health at Einstein and leader of the Cancer Epidemiology Program at the Albert Einstein Cancer Center.

Study participants followed for 10 to 13 years

For a more thorough look at the impact of cancer prevention guidelines, the Einstein team studied data from the National Institutes of Health-AARP Diet and Health Study. In 1995-96, the study collected questionnaires from more than 500,000 people that asked about various aspects of diet and lifestyle. Study participants were between the ages of 50 and 71 at the time of enrollment. They were followed for a median of 10.5 years to determine cancer incidence, 12.6 years to determine cancer mortality and 13.6 years to determine total mortality.

Participants with a previous history of cancer were excluded from the study, yielding 476,396 subjects for analysis. Those subjects were divided into five groups based on how closely they adhered to the ACS guidelines in terms of their body mass index (BMI), physical activity, alcohol intake, and several aspects of diet. During the study period, the enrollees experienced 73,784 cases of cancer, 16,193 cancer deaths, and 81,433 deaths from all causes.

Risk of cancer at specific sites and overall mortality

The researchers also examined the risk of developing cancer at 25 specific anatomic sites. They found 14 sites where people adhering most closely to the guidelines had reduced risks for developing cancer compared to those in the lowest-adherence group. Notable examples were gallbladder cancer (65 percent reduced risk, both sexes combined), endometrial cancer (60 percent), liver (48 percent, males) colon cancer (48 percent, males; 35 percent, females) and rectal cancer (40 percent, males; 36 percent, females).

But adhering to the guidelines was not always associated with lower risk for site-specific cancers. Compared to the least adherent men, for example, the most adherent men had a statistically significant 19 percent greater risk for developing melanoma, although the reason for that increased risk is not clear.

As for the risk of dying from all causes including cancer, men who adhered most closely to the guidelines had a reduced overall mortality risk of 26 percent, while the most adherent women had a reduced overall mortality risk of 33 percent. "Adherence to the guidelines had a slightly bigger effect in never smokers than in former or current smokers," said Dr. Kabat. "But the bottom line is that, even if you smoke--a huge risk factor for certain types of cancer--it's worthwhile to adhere to the guidelines."

Aim for a healthy body weight

Different lifestyle components of the ACS guidelines varied in importance, depending on the outcomes examined in the Einstein study. For reducing overall mortality, a healthy body weight and engaging in physical activity ranked as the two most important factors for both men and women.


The paper is titled, "Adherence to Cancer Prevention Guidelines and Cancer Incidence, Cancer Mortality, and Total Mortality." In addition to Drs. Kabat and Rohan, the other authors are Victor Kamensky, M.S., at Einstein; Charles Matthews, Ph.D., at the National Cancer Institute, Bethesda, MD; and Albert Hollenbeck, Ph.D., at AARP, Washington, D.C. This paper was supported by institutional funds from Einstein. The authors report no conflicts of interest.

About Albert Einstein College of Medicine of Yeshiva University

Albert Einstein College of Medicine of Yeshiva University is one of the nation's premier centers for research, medical education and clinical investigation. During the 2013-2014 academic year, Einstein is home to 743 M.D. students, 275 Ph.D. students, 103 students in the combined M.D./Ph.D. program, and 313 postdoctoral research fellows. The College of Medicine has more than 2,000 full-time faculty members located on the main campus and at its clinical affiliates. In 2013, Einstein received more than $150 million in awards from the National Institutes of Health (NIH). This includes the funding of major research centers at Einstein in aging, intellectual development disorders, diabetes, cancer, clinical and translational research, liver disease, and AIDS. Other areas where the College of Medicine is concentrating its efforts include developmental brain research, neuroscience, cardiac disease, and initiatives to reduce and eliminate ethnic and racial health disparities. Its partnership with Montefiore Medical Center, the University Hospital and academic medical center for Einstein, advances clinical and translational research to accelerate the pace at which new discoveries become the treatments and therapies that benefit patients. Through its extensive affiliation network involving Montefiore, Jacobi Medical Center - Einstein's founding hospital, and three other hospital systems in the Bronx, Brooklyn and on Long Island, Einstein runs one of the largest residency and fellowship training programs in the medical and dental professions in the United States. For more information, please visit, read our blog, follow us on Twitter, like us on Facebook, and view us on YouTube.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.